Publication | Closed Access

Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol

Hematological MalignancyOncologyMyelodysplastic SyndromeBone Marrow FailureMedicineAplastic AnemiaTransfusion-dependent PatientsHematologyPharmacotherapy13-Cis-retinoic AcidPharmacologyCancer ResearchMyeloid Neoplasia